Acute Heart Failure (AHF)
Conditions
Keywords
cardiometry, acute heart failure
Brief summary
The goal of this clinical trial is to assess if electrical cardiometry (EC) could help in managing acute heart failure (AHF). The main questions it aims to answer are: 1. Is there effect of use of cardiometry on rate of use of vasopressors, vasodilators and inotropes? 2. is there effect of use of cardiometry on mortality and hospital length of stay? Researchers compared cardiometry to traditional methods like clinical examination, lung ultrasound and inferior vena cava. Participants were divided into two groups, one managed by cardiometry and the other by traditional methods, then followed till improvement or death and compared regarding use of medications, length of stay and mortality
Detailed description
The purpose of the research is to assess the role of electrical cardiometry in hemodynamic monitoring in studied cases with acute heart failure to guide treatment. This is a prospective controlled research that involved fifty patients, diagnosed with acute heart failure and admitted to critical care units at Alexandria University Hospitals, patients were divided into 2 groups: Group A: was assessed by traditional methods which include: clinical examination including chest auscultation and systolic blood pressure measurement, lung ultrasound and inferior vena cava assessment and managed according to the results of these parameters. Group B: was assessed by electrical cardiometry parameters as cardiac output, thoracic fluid content (TFC) and systemic vascular resistance (SVR) and was managed as following: inotropes up and down titration according to cardiac output readings, use of vasopressors or vasodilators according to SVR readings, doses of diuretics were modified according to TFC readings.
Interventions
DEVICEelectrical cardiometry
use of cardiometry parameters as cardiac output, thoracic fluid content, systemic vascular resistance
OTHERtraditonal methods
clinical examination, lung ultrasound, inferior vena cava
Sponsors
Alexandria University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)
Eligibility
Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No
Inclusion criteria
* acute heart failure
Exclusion criteria
* pregnant females, atrial fibrillation, severe valvular diseases, skin lesions in thoracic area, large pleural effusion
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| mortality and intensive care unit (ICU) length of stay | 7 days | number of days in ICU and mortality in ICU |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| use of vasopressors, vasodilators, inotropes | 7 days | number of patients who needed these medications |
Countries
Egypt
Outcome results
None listed